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Catalytic therapy (CT) is a cancer treatment modality based on the generation of reactive
oxygen species (ROS) using a combination of substrate molecules and a catalyst. The most
frequently used substrate/catalyst pair is ascorbate/Co phthalocyanine (PcCo). In the present
work, herb extracts containing pigments have been studied as a catalyst in place of PcCo.
Extracts from herbs are expected to have efficiency comparable with that of phthalocyanines
but as natural products, to exhibit fewer side effects. The present studies demonstrate that a
combined use of ascorbate and herbal extracts results in ROS production and a significant
decrease in the number of cancer cells after a single in vitro treatment. Treatment with ascorbate
in conjunction with extracts prepared from several medicinal herbs stimulated apoptosis and
disrupted the cell cycle. The number of cells accumulating in the sub-G0/G1 stage of the cell
cycle was increased 2- to 7-fold, and cells in G2/M increased 1.5- to 20-fold, indicating that the
treatment protocol was highly effective in suppressing DNA synthesis and potentially reflecting
DNA damage in the tumor cells. In addition, 20–40% of the cells underwent apoptosis within
24h of completing treatment. Our results suggest that herbal extracts can function as CT
catalysts in the treatment of cancer.
Introduction
Although significant progress has been made over the last
several decades in cancer diagnosis, prevention and
treatment, the development of effective treatment regi-
mens remains one of the greatest challenges in medical
technology. There is presently a number of anticancer
treatment techniques used in medical practice including
chemotherapy, catalytic therapy (CT), radiotherapy and
photodynamic therapy (PDT). Each of the techniques has
both beneficial and detrimental effects. Recently, CT, an
anticancer therapy with activity similar to that of many
chemotherapeutic agents, has emerged as an efficacious
cancer treatment approach. Similar to photodynamic and
radiotherapies, a significant mechanism underlying the
antitumor activity of this approach is the production of
reactive oxygen species (ROS). Potentially, ROS gener-
ated in response to these treatments interact with critical
cellular moieties resulting in the oxidative degradation of
molecules and organelles in cancer cells.
The anticancer effects of CT are elicited through
harnessing the energy from an exogenous source.
Analogous to the use of light in the case of PDT,
donation of energy derived from chemically reactive agents
is used to activate ‘sensitizing drugs’, which enables the
generation of ROS by these intermediate molecules. In
CT, a transition–metal complex acts as the sensitizing drug
or catalyst and a second molecule as the reactant or
substrate (1–6). The resultant radical attack on critical
cellular molecules ultimately leads to tumor growth
suppression, apoptosis and necrosis. The benefits of
treatment with CT are becoming increasingly well
recognized. In fact, in many instances, CT offers distinct
advantages when compared with PDT for anticancer
therapy. For example, PDT requires illumination with
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properly cited.light sources capable of emitting specific wavelengths of
light, a process that limits the use of PDT for treatment of
many inaccessible tumors. Also, poorly localized neo-
plasms and tumors often cannot be effectively treated with
PDT. In contrast, the effectiveness of CT for a diverse
array of tumor types has been demonstrated in vitro in
experiments conducted in Japan, the USA and Russia. In
these studies, the nutrients ascorbate and vitamin B12 were
used. Ascorbate in this approach acts to chemically
activate B12 and its derivatives, or Co phthalocyanine
(PcCo) to become free radical generators (1–12).
Furthermore, in vivo studies using the same CT system
has been successfully conducted in Russia and the USA
(9–21) and clinical trials have been started in Russia (22).
First attempts using CT for anticancer application were
reported in 1983 by Kimoto et al. (23). In recent years,
several promising new CT systems have been developed.
In these studies, it was found that a combination cobalt
or iron phthalocyanine and sodium ascorbate is highly
active in inducing cytostasis and tumor cell deaths. These
CT systems have been patented as agents for binary CT
of malignant tumors (1–2,24–28). In our previous
research (29), we have demonstrated that porphyrins
are promising CT agents as well. Currently, ascorbate is
considered the most suitable substrate for CT; it is widely
accepted because it is a dietary component and many
human tumors accumulate ascorbate to a greater extent
than do normal tissues (30,31). Ascorbate is easily
oxidized by oxygen in the presence of transition metal
ions and produces ROS such as H2O2,O 2
  and OH
 .
Moreover, some products of ascorbate oxidation have
significant antitumor effects themselves.
In addition, in previous studies, we have shown that
ascorbate dramatically increases the efficiency of PDT.
Apparently, the efficient generation of oxygen radicals by
ascorbate intensifies the antitumor effect. These findings
led to the hypothesis that ascorbate along with photo-
sensitizers may act by direct tumor cell damage resulting
in apoptosis (32,33). Recently, it has been demonstrated
that CT can achieve efficiency comparable with that of
PDT (1). Similarities observed in the responses elicited
by these treatments support the thesis that common
processes, potentially mediated by ROS, may underlie
both treatment regimens. It is our hypothesis that CT,
like PDT, is effective in cancer treatment through
eliciting a sequela of effects including direct cell
killing, ROS generation, vascular damage, inducing
inflammatory responses and the stimulation of nonspe-
cific or specific immune effector cells (34–47).
The process of catalytic oxygenation of ascorbate by
cobalt (II) octa-4,5-carboxyphthalocyanine (PcCo) is
shown in Scheme 1 (48).
At the current time,  36–40% of cancer patients in
USA use complementary alternative medicine (CAM)
approaches, including therapy with herbs; unfortunately
the scientific research in this area is far from
comprehensive. Undeniably, there is a pressing need to
use objective procedures to test the effectiveness of
putative remedies and help distinguish therapeutically
induced changes in underlying pathologic conditions
from the subjective relief that might follow any interven-
tion (49–52). Hypericin from St. John’s Wort is one
herbal remedy commonly used in CAM. Hypericin has
an array of demonstrated and claimed physiological
effects; however, its activity as a photosensitizer that
facilitates ROS generation in response to light is well
documented. Interestingly, inclusion of this herb in a CT
binary system excited the chemiluminescent oxidation of
luciferin by the luciferase (53). In addition, it has been
shown that treatment with Hypericin (HY) and
Hyperforin (HP) (abundant components of St John’s
Wort) inhibits the growth of K562 and U937 leukemia
cells, and the brain glioblastoma cell line LN229. In these
studies, treatment of tumor cells with HP resulted in a
dose-dependent generation of apoptotic oligonucleo-
somes, DNA-laddering and apoptosis-specific morpholo-
gical changes (54,55). Also, recently there has been
increasing interest in potential pharmaceutical activities
of anthocyanins. These pigments have been implicated in
cancer chemoprevention, acting through several mechan-
isms, including modulation of ROS levels, an effect that
is important for the prevention of carcinogenesis, as well
as by inducing apoptosis in tumor cells. In addition, in
current studies, the bioavailability and structure–activity
relationship of anthocyanins have been reviewed (56–58).
In the present studies, total herbal extracts were
examined. The use of total extracts rather than isolated
pigment fractions was based on findings demonstrating
that purified Hypericin have only weak inhibitory effects
on cell growth and no apparent role in apoptotic cell
death, whereas the Hypericum flower extract elicited a
significant concentration-dependent and long-lasting inhi-
bition of cell growth and induced apoptosis. This work
unveiled a potential role of Hypericum perforatum L.i n
cancer therapy and strongly supports the hypothesis that
agents, other than Hypericin, present in the total extract
may contribute to the antitumor activity.
These findings prompted us to examine the activity of
extracts containing Hypericin and anthocyanin pigments
including preparations derived from the herbs St John’s
Wort (Hypericum perforatum), Bilberry (Vaccinium
myrtillus) and Blue Malva (High mallow) for use in
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Scheme 1. The process of catalytic oxygenation of ascorbate by cobalt
(II) octa-4,5-carboxyphthalocyanine (Pc Co).
204 Herbal extracts as CT catalysts for cancerCT. In the present study, we tested the hypotheses that
extracts from whole herbs contained Hypericin and
anthocyanin pigments could replace the cobalt (II) octa-
4,5-carboxyphthalocyanine in CT, and that herbs con-
taining these pigments would be effective in activating
catalytic systems.
Materials and Methods
Chemicals
Unless otherwise indicated, all chemicals were purchased
from Sigma (St Louis, MO, USA).
Cell Cultures
MCF-7 human breast cancer cells, PAM 212 murine
keratinocytes, and B-16 mouse melanoma cells were
purchased from ATCC (Manassas, VA, USA). Cells
were grown in Dulbecco’s modified Eagle’s medium
(DMEM), supplemented with 10% heat-inactivated fetal
serum (FCS) (HyClone, Logan, UT, USA), 2mM
l-glutamine, 100U/ml penicillin and 100U/ml streptomy-
cin (Invitrogen, Carlsbad, CA, USA), and maintained at
37 C in an atmosphere containing 5% CO2. Cells were
seeded on 6-well plates (10000 cells/well) 24h before
treatment for cell growth assays. In some experiments,
CT was initiated a day after cell seeding at concentrations
indicated in the text. Cell proliferation was evaluated at
various intervals 1–6 days after treatment. Duplicate
plates were used as controls in all experiments. For
studies focusing on apoptotic cell death and the effects of
treatments on cell cycle distribution, cells were plated in
6-well plates (10000 cells/well) and treatment with CT
was initiated 4 days after cell seeding (before cells
achieved full confluence); drugs were used at concentra-
tions indicated in the text. Experiments evaluating
apoptosis and cell cycle status were conducted 2–24h
after CT treatment.
Herb Extracts Preparation and Treatment
We recognize that extracts from whole herbs contain
numerous moieties in addition to pigments and we
cannot exclude the possibility that other components of
the herbal extracts may influence our results. In fact in
many instances, it has been demonstrated that pure
extracts from plants often exhibit diminished efficiency
when compared with whole extracts. Therefore, in the
present studies we have examined whole herbal extracts.
St John’s Wort extracts were prepared from fresh wild
flowers (obtained at Sandy Hook, NJ, USA), the identity
of the herb was positively established according to the
Herb Book by John Lust (59), extracts were prepared
using pure St John’s Wort flower; Bilberry extracts were
prepared using pulverized, dried whole bilberry berries or
flowers (Alvita, American Fork, UT, USA); Blue Malva
extracts were derived from Blue Malva Tea containing
only tea flowers (Kroeger Herb Products Co. Inc.,
Boulder, CO, USA). The extracts contained pure Blue
Malva or St John’s Wort flowers, and hydrated in 5ml
distilled water or in 70% ethanol/0.08g dry flowers.
Twenty milliliters of water extract and/or 5ml of ethanol
extract were added to each well of a 6-well plate
containing MCF-7 -Human breast adenocarcinoma cell
line, PAM 212- murine keratinocytes SJW- St. John’s
Wort or B-16 cells in 0.5ml of phenol red-free DMEM.
Extracts from Bilberry flowers were resuspended in water
(0.08g dry on 5ml) and 20ml was added to each well of a
6-well plate containing MCF-7, PAM or B-16 cells in
0.5ml of clear DMEM. Cells were incubated with the
herbal preparations for 1h then the medium was
exchanged for fresh DMEM (without herbal extracts)
and the catalytic mixture (ascorbic acid, 0.07mM and
CuSO4, 0.07mM) was added to the wells. Cells were then
incubated with the catalytic mixture for an additional
hour and the medium then exchanged to growth DMEM.
For growth experiments, the cells were allowed to
proliferate for up to 1 week; in some experiments cells
were analyzed at various intervals 30min–24h for
evidence of apoptosis and alterations in the cell cycle.
For these experiments optimized conditions were
employed; optimal concentrations of the extracts, and
treatment durations were determined using various
concentrations of the extracts and components of
activation mixture (data not shown). The time points
used for the analysis (1 week for cell growth and 24h for
cell cycle and apoptosis) have been chosen according the
common practice for these procedures.
Statistical Analysis
All experiments were repeated at least three times in the
course of this study. Three controls groups have been
used: (i) untreated cells, (ii) treated by activation mixture,
(iii) treated by herb extracts without activation mixture.
Statistical variation was determined using the Student’s
t-test calculation. In some instances, representative results
are presented. Plus or minus standard deviation ( SD)
was calculated where appropriate.
Ground State Absorption Spectra
Ground state absorption spectra were recorded on an
HP-8452A UV-visible spectrophotometer with 2nm
resolution. Spectra of extract from Blue Malva were
determined using 0.08g of dry flowers in 5ml phosphate
buffered saline (PBS), 0.01mM ascorbate and
0.02mM CuCl2.
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Cells were seeded in 6-well plates 24h prior to CT
treatment. CT treatment was carried out as described
earlier in this article. Sample size was 1 sample/well with
3–6 parallel measurements. Cells proliferation was
determined 6 days after treatment using a Coulter
Counter model Z B1, Coulter Electronic Inc., Hialiah,
FL, USA. Baseline variability was not significant in any
of the experiments.
Cell Cycle Analysis
Cells were seeded in 6-well plates 4 days prior to CT
treatment. CT treatment was carried out as described
earlier in this article. Control and treated cells were
harvested within the next 24h, washed twice in PBS,
fixed with 70% ethanol for 30min at room temperature,
washed three times with PBS, resuspended in the staining
buffer (10mM PIPES, pH 6.8, 0.1M NaCl, 0.1% Triton
X-100, 2mM MgCl2), treated with DNase-free RNase
I (100mg/ml) for 30min at room temperature, and stained
with propidium iodide (PI, Molecular Probes, Eugene,
OR, USA) at a concentration of 10mg/ml. Stained cells
were analyzed by flow cytometry using a Beckman
Coulter flow cytometer.
Annexin V and PI Staining
Cells were seeded in 6-well plates 4 days prior CT
treatment. CT treatment was carried out as described
earlier in this article. Both adherent and detached cells
from untreated and CT exposed samples were collected,
washed twice in PBS and incubated with the fluorescent
indicator dies Annexin V and PI according to the
manufacturer’s protocol (Sigma, St Louis, MO, USA).
Control populations consisted of unstained cells and cells
individually stained with only Annexin V or PI. Cells
were analyzed by flow cytometry using a Beckman
Coulter flow cytometer. The fluorescence emission of
10000 cells/treatment was collected in each channel.
ROS Measurement
The generation processes of ROS can be monitored
using the luminescence analysis or also fluorescence
methods. The intracellular ROS generation of cells can
be investigated using 20,70-dichlorfluorescein-diacetate
(DCFH-DA) as a well-established compound to detect
and quantify intracellular produced H2O2. The conver-
sion of the non-fluorescent DCFH-DA to the highly
fluorescent compound 20,70-dichlorfluorescein (DCF)
happens in several steps. First, DCFH-DA is transported
across the cell membrane and deacetylated by esterases to
form the non-fluorescent 20,70-dichlorfluorescein
(DCFH). This compound is trapped inside of the cells.
Next, DCFH is converted to DCF through the action of
peroxide rated by the presence of peroxidase.
Immediately after CT treatment, cells were incubated
for 30min with 5uM DCFH-DA in phenol and serum-
free medium. Cells were analyzed on Coulter Profile flow
cytometer.
Results
Ground State Absorption Spectra
Full-width half-maximum (FWHM) of the 620nm band
in the UV/VIS spectra of Blue Malva under CT has been
changed from 170 to 100nm (Table 1). The ground state
absorption which has been recorded on an HP-8452A
UV-visible spectrophotometer with 2nm resolution has
been changed from 0.42 to 0.11 units. It indicated the
bleaching of pigment under CT influence.
Cell Growth Suppression
Data were calculated using the formula 1: X (data in
Table 2)=[(O 100%)/C). Here, O is the number of
cells following treatment by CT; C is the number of cells
treated by activation system alone (control cells) and X is
the difference between the cells treated by CT in
comparison with cells treated by the activation system
only (%). St John’s Wort alone caused little decreasing in
Table 2. CT with St John’s Wort inhibits cell proliferation (data has
been calculated by formula 1)
Parameters St John’s
Wort alone
St John’s
Wort with
activation
mixture
PAM
Cell count (mean,%) 94.1 3.1 68.9 7.6
P <0.006
Repetition of experiment
Cell count (mean,%) 93.9 2.7 71.1 6.1
P <0.004
P (between 1st and
2nd experiments)
<0.64
Human keratinocytes
Cell count (mean,%) 96.7 3.2 94.7 4.1
P <0.54
Table 1. Ground state absorption spectra of Blue Malva
Mixtures FWHM (nm),
 620nm
Absorbance,  620nm
Blue Malva in PBS 170 0.42
Blue Malva in PBS
+activation mixture
100 0.11
206 Herbal extracts as CT catalysts for cancercell counting 94.1 3.1. But St John’s Wort with
activation mixture significantly decreased the number of
cells more than 30%. There were no difference between
this experiment and its repetition (P<0.64). The CT
with Bilberry also demonstrated the ability of CT to
decrease the number of cancer cells (Fig.1).
However, the number of normal cells (human kerati-
nocytes) has not been affected by CT (Table 1).
Cellular DNA and Early Stages of Apoptosis Analysis
The formula 2: X (data in Table 3)=O A was used in
our calculations; in this formula O is the experimental
data (CT with herbs), and A is the control data (CT with
activation mixture alone). The number of cells accumu-
lating in the sub-G0/G1 stage of the cell cycle was
increased 2- to 7-fold for St John’s Wort, and cells in
G2/M increased 1.5- to 20-fold for Bilberry and Blue
Malva (Table 3). As demonstrated in Table 4, treatment
by CT using herbs significantly increased the number of
dead (PI staining cells); 2-folds for St John’s Wort and
12-fold for Bilberry. Also, the number of cells undergoing
early stage of apoptosis (Annexin staining cells): 6.3-fold
for St John’s Wort; 4.2-fold for Bilberry and 3.4 for Blue
Malva. We could see on the Fig. 3A that cells had been
damaged by CT with St John’s Wort plus activation
mixture. All cells on the picture show some signs of
apoptosis (some apoptotic cells are pointed by arrows
a1; a2; a3; a4; a5) which includes: cell shrinkage and
rounding due to the breakdown of the proteinaceous
cytoskeleton; the cytoplasm appears dense, and the
organelles appear tightly packed; chromatin undergoes
condensation into compact patches against the nuclear
envelope in a process known as pyknosis, a hallmark of
apoptosis; the nucleus breaks into several discrete
chromatin bodies or nucleosomal units due to the
degradation of DNA; the cell membrane shows irregular
buds known as blebs; the cell breaks apart into several
vesicles called apoptotic bodies. Figure 3B shows that
activation mixture does not damage the cells and Fig. 3C
shows that St. John’s Wort alone is damaging only for
few cells (one apoptotic cell is pointed by arrow c1).
The measurements of ROS by DCFH method have
been shown the increase in ROS generation during CT
with St. John’s Wort and Blue Malva up to 14- and
8-fold, respectively.
Discussion
In the process of CT with phthalocyanines, active agents,
known to kill cancer cells, are produced including the
ROS OH
  (hydroxyl radical) and H2O2. We hypothesized
that reaction of herbal pigments with CT would also
result in the generation of ROS (Scheme 1); therefore,
cellular ROS generation in response to herbal extracts
and CT was examined. In previous studies, different
experimental methods have been used to evaluate ROS
generation in CT. An approach of particular interest
because it also yields information concerning the photo-
chemistry of these compounds is the examination of the
spectral properties of various types of pigments with and
without CT. In this regard, it is well known that active
oxygen species are involved in the photo-bleaching
process. When degraded by the attack of the self-
generated active oxygen species during PDT, the photo-
sensitizer forms photoproducts, many of which can be
identified by dramatic decreases in the visible spectral
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Figure 1. Decreases in the numbers of B-16 cells after CT with Bilberry
(Bill, data have been calculated according to formula 1) with various
concentrations of activation mixture A and A dissolved in 10 or 100
times [Bill alone, Bill+ (A:100), Bill +(A:10), Bill +A]. Cells were
seeded in 6-well plates 24h prior to CT treatment. CT treatment was
carried out as described above. Sample size was 1 sample/well with 3–6
parallel measurements. Cells proliferation was determined 6 days after
treatment using a Coulter Counter model Z B1, Coulter Electronic Inc.,
Hialiah, FL, USA. Baseline variability was not significant in any of the
experiments.
Table 3. CT influence on the cell cycle parameters
Parameters St John’s Wort St John’s Wort+AM Bill Bill+AM Malva Malva+AM
Sub G0/G1
Mean SD 1.2 0.3 15.7 2.5 3.3 0.6 5.1 1.9 1.00 0.3 1.3 0.5
P <0.001 <0.2 <0.4
G2/M
Mean  SD 4.0 2.6 5.4 1.3 1.0 0.5 20.1 6.8 1.0 0.6 3.9 0.9
P <0.5 < 0.008 <0.01
eCAM 2010;7(2) 207bands (so-called self-sensitized photo-oxidation).
Similarly, bleaching of pigments in the process of CT is
also caused by self-generated ROS. Therefore, we
reasoned that a loss of absorption of the model mixtures
during CT is likely to represent pigment bleaching. This
has been termed self-sensitized catalytic oxidation. In our
first studies, self-sensitized bleaching of Blue Malva in
CT was examined (Table 1). Treatment with ascorbate
along with Cu
2+ ions resulted in changes in FWHM of
the 620nm band in the UV/VIS spectra indicating that
CT treatment induced bleaching (Table 1). This self-
catalytic bleaching indicates that ROS produced during
the treatment resulted in pigment bleaching, demonstrat-
ing that CT with Blue Malva is mediated by ROS
generation. The direct measurement of ROS in cells
treated with CT will be done in the next research. Also,
antioxidants will be tested to prove the ROS mechanism
As demonstrated in Table 2, our preparations of
St John’s Wort and Bilberry alone had little effect on
cell viability. In contrast, when activated by CT we
observed a dramatic decrease in tumor cell numbers. In a
manner similar to the activation of cobalt (II) octa-4,
5-carboxyphthalocyanine (PcCo) by ascorbate, in these
experiments responses to CT were mediated by the
catalytic oxygenation of ascorbate by the herbal pigments
(Scheme 1). No significant differences were observed
between the numbers of cells receiving no treatment and
of cells treated with the activation mixture alone (data
not shown). Proliferation of cells treated with activation
mixture alone was determined using the calculation
according to formula 1. CT treatment with activated
St. John’s Wort resulted in decreases of approximately
30% in the number of PAM 212 squamous carcinoma
cells; similar results were observed in experiments
analyzing the effects of CT with St John’s Wort on
B-16 melanoma cells. Repetition of the experiments with
St John’s Wort clearly demonstrated significant reprodu-
cibility (P<0.64). In additional studies the effects of
Bilberry in CT were also examined. As exhibited in
Fig. 1, CT treatments using Bilberry resulted in dose-
dependent decreases in tumor cell numbers. Similar to
our studies using St. John’s Wort, in these experiments
the herb extract without the CT activation mixture had
minimal effects on tumor cell proliferation. In these
experiments, activated Bilberry extracts dramatically
inhibited cell proliferation. Tumor cell numbers were
depleted up to 40% when examined 6 days following
treatment, an effect that was dependent on the concen-
tration of the herbal extracts (100 dilution of the herbal
mixture to undiluted extract). Taken together, these data
demonstrated that both St John’s Wort and Bilberry are
effective in CT and that inhibition of proliferation in
response to the herbal CT mixtures is dependent on the
concentration of the herbal extracts.
Although more that 50 years have elapsed since
progression through the cell cycle was first described for
mouse sertoli cells, analysis of the diverse paths of tumor
cells traversing the cycle still proves an effective mechan-
ism for obtaining information about the progression of
neoplastic diseases (39). In fact, alterations to the rate at
which cellular DNA levels multiply from a singlet
complement (G1) to fully duplicated, ready to divide
G2M levels, is perhaps one of the most efficient measures
of the efficacy of anticancer drugs. Therefore, we next
examined the effects of CT treatment with herbs on the
cell cycle progression of cells from two tumor cell lines,
PAM 212 squamous cell carcinoma and B16 melanoma
cells. In these experiments the influence of the herbal
extracts from St John’s Wort, Bilberry and Blue Malva in
combination with activation mixture on the cell cycle were
examined using PI in conjunction with flow cytometry.
Cell DNA content was analyzed and levels reflecting the
G0/G1, S, G2/M stages of the cell cycle as well as and
sub-G0/G1 cells (apoptotic cells) were defined.
As demonstrated in Table 3 and Fig. 2, treatment with
herb extracts, and with the extracts in combination
with activation mixtures, increased the percentage of cells
with less than a singlet component of DNA (the sub-G0/
G1 fraction), a fraction presumed to contain a significant
proportion of apoptotic cells, and the percentage of cells
in the G2/M fraction, a process indicative of cell cycle
arrest. Potentially, damage to DNA and other critical
cellular molecules produced by CT treatment mediated
these effects. In this regard, it is well recognized that the
cellular responses to the injury and stress induced by
treatment with anticancer agents are key determinants of
drug activity. Checkpoint proteins that control the
normal passage of cells through the cell cycle play a
Table 4. CT with herbs induces unscheduled cell death and apoptosis in MCF-7 breast cancer cells: flow cytometric evaluation of PI and Annexin
V fluorescence
Parameters St John’s Wort St John’s Wort+AM Bill Bill+AM Malva Malva+AM
Dead (PI staining) cells, (%)
Mean SD 18.5 4.5 39.5 4.6 0.8 0.1 9.8 2.2 15.1 4.4 23.2 5.4
P <0.005 <0.002 <0.11
Apoptotic (Annexin staining cells), (%)
Mean SD 2.9 0.6 18.3 3.9 6.3 2.1 13.3 3.1 5.6 1.5 19.2 2.9
P <0.002 <0.03 <0.002
208 Herbal extracts as CT catalysts for cancerpivotal role in the responses to injury. In fact, increasing
evidence indicates that defects in one or more cell cycle
checkpoints often act to enable transformed cells to
proliferate. However, these same defects may also render
some cancer cells more vulnerable to inhibition of a
second checkpoint, thereby enhancing the overall sensi-
tivity to some anticancer treatments. (58). Our findings
indicate that these processes may underlie the responses
to St. John’s Wort. Treatment with this herb alone
increased the percentage of cells unable to traverse the
G2/M point, however, CT with the St. John’s Wort
extract not only enhanced this effect, this treatment also
dramatically increased the number of sub-G0/G1 (apop-
totic) cells (Fig. 3). Interestingly, Hostanska (54) and
Schempp (55) previously reported that St. John’s Wort
alone exhibits low levels of inhibition to cancer cell
proliferation, a finding that may be reflected in our
findings of increases in G2/M cells following treatment
with St. John’s Wort without activation mixture.
Furthermore, our findings that CT with St. John’s
Wort treatment significantly increased the number of
apoptotic cells (sub-G0/G1) cells, and that CT with
Bilberry and Blue Malva also caused G2/M checkpoint
arrest, clearly indicate that when used in CT these herbal
extracts are potent modulators of the cell cycle.
Potentially, the unique pigment molecules in each herbal
extract may mediate distinct responses. These findings
prompted us to further evaluate the apoptotic effects of
CT treatment. Changes in the plasma membrane of cell
surface are among the earliest identifiable features of
cells undergoing apoptosis, and the exclusion of PI is
a sensitive indicator of cell viability. In cells undergoing
apoptosis the membrane phospholipid phosphatidylserine
(PS) are translocated from the inner to the outer leaflet
of the plasma membrane thereby exposing PS.
In these studies, the early stages of apoptosis of cancer
cells after CT treatment were evaluated by flow
cytometry using Annexin V, a fluorescent indicator die
which binds to phosphotidyl serine in the cell membrane,
in conjunction with the viable die PI (Table 4).
As demonstrated in Table 4, treatment by CT using
herbs significantly increased the number of dead
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Figure 2. Cell cycle of herbs extracts. (A) Control (activation mixture). (B) St John’s Wort with activation mixture. (C) Malva with activation
mixture. (D) Bilberry with activation mixture. Cells were seeded in 6-well plates 4 days prior CT treatment. CT treatment was carried out as
described above. Control and treated cells were harvested within the next 24h. Stained cells were analyzed by flow cytometry using a Beckman
Coulter flow cytometer.
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resulted in significant increases in the number of cells
undergoing apoptotosis (Annexin staining cells). Of the
herbal extracts examined, St John’s Wort extracts had the
greatest effects on the G1 point of cell cycle whereas Blue
Malva and Bilberry were more active in regulating
accumulation in G2/M (Tables 3 and 4 and Fig. 2).
However, CT using each of three herbal extracts led to
significant increases in the numbers of apoptotic cells.
Unique proteins regulate the G1 and G2 checkpoints; our
findings that distinct herbal extracts differentially alter
passage through these checkpoints may reflect distinct
effects elicited by different herbal extracts on these
proteins. Similar to hypericin, pigments from St John’s
Wort are large planar molecules with little structural
flexibility, whereas the blue anthocyanin pigments found
in Bilberry and Blue Malva are smaller and flexible.
These characteristics may be important for specific
molecular interactions with different cell cycle regulators
and underlie the differences in the activity of the pigment
sub-classes. In addition, the gross structural dichotomies
may also render some pigments more susceptible to
destruction by ROS generated during CT. Our findings
indicate that CT with herbal extracts generates ROS,
increases the percentage of apoptotic cells and decreases
the proliferation of cancer cells. Cell damage and
inhibition of tumor cell proliferation were found to be
dependent on the presence of the catalytic mixture. Taken
together, the results of these studies indicate that CT
treatment with pigmented herbal extracts results in
extensive death in tumor cells and that all of the extracts
used were effective in activating apoptosis.
It has been previously demonstrated that CT leads to
ROS generation in cancer cells (29). As indicated in the
flow cytogram exhibited in Fig. 4, the DCFH peak
position indicates that enhanced levels of ROS are found
in PAM 212 cells after CT with SJW (from 7.2 to 101
fluorescence units) and after CT with Malva (from 7 to
58.7 channel units) (Fig. 4). In these studies, the data are
presented on a four-decade log scale and indicate that
ROS levels have been increased 14- and 8-folds,
respectively (Table 5).
We have employed rigorous and scientifically valid
approaches for evaluating the effects of CT with herbal
extracts on tumor cells. In the present studies, our
preliminary results suggested that whole extract pigments
are efficacious as anticancer agents. The effects of
purified pigments will be examined in future research.
Also, we did not analyze direct ROS production by all of
the preparations examined in live cells. However, indirect
evidence has been obtained from spectral bleaching
studies. In future studies, we plan to examine the effects
of individual extract pigments on cellular ROS
production.
In future studies, we will examine the effects of purified
individual pigments as well as those of herbal extracts
on intracellular oxidant levels. We plan to measure the
ROS production in the cells and sample mixtures by
flow cytometry using dichlorofluorescin diacetate
(DCFH-DA).
Another important issue with CT as well as with all
other drug therapies is the potential for discrepancies
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Figure 4. ROS levels in cancer cells after CT: A—control, B—CT with
Blue Malva, C—CT with St John’s Wort. The intracellular ROS
generation of cells has been investigated using 20,70-dichlorfluorescein-
diacetate (DCFH-DA)#as a well-established compound to detect and
quantify intracellular produced H2O2. Immediately after CT treatment
cells were incubated for 30min with 5 mM DCFH-DA in phenol and
serum-free medium. Cells were analyzed on Coulter Profile flow
cytometer.
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Figure 3. B-16 mouse melanoma cells with CT with St John’s Wort.
(A) St John’s Wort+ activation mixture. (B) Activation mixture.
(C) St John’s Wort. For these experiments optimized conditions were
employed; optimal concentrations of the extracts, and treatment
durations were determined using various concentrations of the extracts
and components of activation mixture (data not shown). The time
points used for the analysis (1 week for cell growth and 24h for cell
cycle and apoptosis) have been chosen according to the common
practice for these procedures. We could see on the (A) that cells had
been damaged by CT with St John’s Wort plus activation mixture. All
cells on the picture show some signs of apoptosis (some apoptotic cells
are pointed by arrows a1; a2; a3; a4; a5), which includes: cell shrinkage
and rounding due to the breakdown of the proteinaceous cytoskeleton;
the cytoplasm appears dense and the organelles appear tightly packed;
chromatin undergoes condensation into compact patches against the
nuclear envelope in a process known as pyknosis, a hallmark of
apoptosis; the nucleus breaks into several discrete chromatin bodies or
nucleosomal units due to the degradation of DNA; the cell membrane
shows irregular buds known as blebs; the cell breaks apart into several
vesicles called apoptotic bodies. (B) shows that activation mixture does
not damage the cells and (C) shows that St John’s Wort alone is
damaging only for few cells (one apoptotic cell is pointed by arrow c1).
210 Herbal extracts as CT catalysts for cancerbetween the results of in vitro and in vivo studies. Drug
efficacy can be decreased in vivo due to metabolism of the
drug or interactions with other biological structures, or
due to small accumulation of components in tumor cells.
Thus, it is necessary to transport drugs (e.g. catalysts and
the activation mixture) to tumors safely without chang-
ing, destroying, or decreasing the concentration, as well
as to achieve a high concentration of components in
tumor cells. We have solved this problem in one of our
previous studies using magnetically guided liposomes
loaded with photosensitizer in in vivo PDT experiments
(60). It has been shown that this guided transport
dramatically increased the concentration of photosensiti-
zer at the tumor site and PDT efficiency. Most recently
this method has been undertaken by researchers at
University at Buffalo where they demonstrated an
approach for drug delivery in which an applied magnetic
field directs the accumulation in tumor cells. Adaptation
of this technique to CT may lead to treatments that
exploit the advantages of PDT and yet have the potential
to reduce drug accumulation in normal tissues (61).
Increased effectiveness of CT may result from the use of
the same guided delivery system for distinct treatment
components. Moreover, new products such as polymeric-
and ceramic-based nanoparticles, combined with specific
antibodies may be tested as well. This complete system of
guided transport (magnetically guided, antibody com-
bined drug-loaded nanoparticles) may act to facilitate
delivery of the components of CT to tumors with little
change or loss. Using these techniques to improve the
pharmacokinetic profiles of CT components is likely to
facilitate in vivo CT studies, and we will investigate these
approaches in our future research.
Conclusions
Our findings clearly indicate that CT treatments with
herb extracts is effective in suppressing tumor cell
proliferation and inducing both unscheduled and apop-
totic cell death in cancer cells, effects potentially due to
damage to critical cellular molecules. However, many of
the molecular mechanisms underlying these responses
remain poorly defined. It is our contention that the
present results demonstrate the efficacy of St John’s
Wort, Blue Malva and Bilberry extracts as potential
anticancer agents, and that these studies also suggests the
need for further investigations into the anticancer
activities of these herbs.
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